Press Releases

Date Title
06/17/20
Summary ToggleT2 Biosystems Regains Compliance with NASDAQ Listing Requirements Printer Friendly Version LEXINGTON, Mass. , June 17, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that on June 16, 2020 it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC
06/15/20
Summary ToggleT2 Biosystems Announces Changes to Board of Directors Printer Friendly Version Three new appointments add significant clinical and commercialization experience and expand board diversity LEXINGTON, Mass. , June 15, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced three new Board of
05/19/20
Summary ToggleT2 Biosystems’ Bacteria Panel Wins “Best New Technology Solution - Diagnostics" Award in MedTech Breakthrough Awards Printer Friendly Version Achievement Underscores the Clinical Value of Company’s Rapid Diagnostic Test for Sepsis-causing Bacterial Pathogens in Bloodstream LEXINGTON, Mass. , May 19, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced it
05/05/20
Summary ToggleT2 Biosystems Announces First Quarter 2020 Financial Results Printer Friendly Version LEXINGTON, Mass. , May 05, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the first quarter ended March 31, 2020 . Recent Highlights Achieved first quarter total revenue of $2.5 million
04/21/20
Summary ToggleT2 Biosystems to Report First Quarter 2020 Financial Results on May 5, 2020 Printer Friendly Version LEXINGTON, Mass. , April 21, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the first quarter of 2020 after market close on Tuesday, May 5, 2020.
04/15/20
Summary ToggleT2 Biosystems Reports Granting of Inducement Award Printer Friendly Version LEXINGTON, Mass. , April 15, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to four new employees. The awards were made on March 18, 2020 and April 14, 2020 under T2 Biosystems’
03/24/20
Summary ToggleT2 Biosystems Announces Worldwide Licensing Agreement of COVID-19, Novel Coronavirus Assay from Hackensack Meridian Health’s Center for Discovery and Innovation Printer Friendly Version New COVID-19 assay will be adapted to run on T2 Biosystems’ FDA-cleared T2Dx® Instrument LEXINGTON, Mass. , March 24, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it has entered into a worldwide
03/24/20
Summary ToggleT2 Biosystems Announces Preliminary First Quarter 2020 Financial Results Printer Friendly Version Suspends 2020 Financial Guidance LEXINGTON, Mass. , March 24, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced unaudited, preliminary financial result estimates for the quarter ended March 31, 2020 , and
03/19/20
Summary ToggleT2 Biosystems Receives Multiyear Innovative Technology Contract from Vizient, Inc. Printer Friendly Version Contract recognizes products that bring improvements to the health care industry LEXINGTON, Mass. , March 19, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it was awarded an Innovative Technology
02/24/20
Summary ToggleT2 Biosystems Announces Fourth Quarter and Full Year 2019 Financial Results Printer Friendly Version LEXINGTON, Mass. , Feb. 24, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the fourth quarter and full year ended December 31, 2019 . Fourth Quarter and Recent Business and Financial